Claims for Patent: 7,015,018

Summary for Patent: 7,015,018

Title:	Amplification method for detection of target nucleic acids involving-fluorescence energy transfer
Abstract:	A method for detecting the presence of a target nucleic acid sequence in a sample, said method comprising subjecting said sample to an amplification reaction using a set of nucleotides, at least one of which is labelled with a first label, and a reagent comprising an amplification primer which can hybridise to said target sequence when in single stranded form and which is connected at its 5\' end to a probe which carries a second label by way of a chemical linking group, said labelled probe being of a sequence which is similar to that of the said target sequence, such that it can hybridise to a complementary region in an amplification product, and wherein one of the first or the second label comprises a donor label and the other comprises an acceptor label, the donor label comprising a fluorescent molecule which is able to donate fluorescent energy to the acceptor label; and monitoring fluorescence of said sample. The method can be used to quantitate the amount of target nucleic acid in the sample as well as to determine sequence characteristics. Kits for effecting the method are also claimed.
Inventor(s):	Lee; Martin Alan (Salisbury, GB), Leslie; Dario Lyall (Salisbury, GB)
Assignee:	The Secretary of State for Defence in Her Brittanic Majesty\'s Government of the United Kingdom of Great Britain and Northern Ireland. (Salisbury, GB) N/A (N/A)
Application Number:	10/048,752
Patent Claims:	1. A method for detecting the presence of a target nucleic acid sequence in a sample, said method comprising subjecting said sample to an amplification reaction using a set of nucleotides, at least one of which is labelled with a first label, and a reagent comprising an amplification primer which can hybridise to said target sequence when in single stranded form and which is connected at its 5' end to a probe which carries a second label by way of a chemical linking group, said labelled probe being of a sequence which is similar to that of the said target sequence, such that it can hybridise to a complementary region in an amplification product, and wherein one of the first or the second label comprises a donor label and the other comprises an acceptor label, the donor label comprising a fluorescent molecule which is able to donate fluorescent energy to the acceptor label; and monitoring fluorescence of said sample. 2. A method according to claim 1 wherein the said first label comprises a donor label and said second label comprises the acceptor label. 3. A method according to claim 1 wherein the acceptor label is a fluorescent molecule which emits energy at a characteristic wavelength. 4. A method according to claim 3 wherein the acceptor label is a rhodamine dye or other dyes such as Cy5. 5. A method according to claim 1 wherein the acceptor label is a dark acceptor such as DABCYL, Methyl Red or a QSY-7 diarylrhodamine dye. 6. A method according to claim 1 wherein the labelled nucleotide is labelled uracil-containing nucleotide. 7. A method according to claim 1 wherein all nucleotides used in the amplification reaction are labelled. 8. A method according to claim 1 wherein the amplification reaction comprises the polymerase chain reaction (PCR). 9. A method according to claim 1 wherein the acceptor molecule is a fluorescent molecule and wherein fluorescence of both the donor and the acceptor molecules are monitored and the relationship between the emissions calculated. 10. A method according to claim 1 wherein the fluorescent signal from the sample is monitored throughout the amplification reaction and the results used to quantitate the amount of target sequence present in the sample. 11. A method for detecting nucleic acid amplification comprising: performing nucleic acid amplification on a target polynucleotide in the presence of (a) a nucleic acid polymerase, (b) a set of nucleotides, at least one of which is labelled with a first label and (c)a reagent comprising an amplification primer which can hybridise to said target sequence when in single stranded form and which is connected at its 5' end to a probe which carries a second label, by way of a chemical linking group, said labelled probe being of a sequence which is similar to that of the said target sequence, such that it can hybridise to a complementary region in an amplification product, and wherein one of the first or second labels comprises a donor label which is able to donate fluorescent energy to the other of the first or second labels which comprises an acceptor label able to absorb fluorescent energy from said donor molecule, said primer being capable of hybridising to said target polynucleotide; and monitoring changes in fluorescence during the amplification reaction. 12. A method according to claim 11 wherein the amplification is carried out using a pair of primers which are designed such that only the target nucleotide sequence within a DNA strand is amplified. 13. A method according to claim 1 wherein the probe is specific either for a splice region of RNA or an intron in DNA, so that only one of amplified RNA or amplified DNA is detected and/or quantitated. 14. A method for determining a characteristic of a sequence, said method comprising (a) amplifying said sequence using a set of nucleotides, at least one of which is labelled with a first label, and a reagent comprising an amplification primer linked by way of a chemical link at its 5' end to a probe which comprises a sequence which is similar to that of a region of the target sequence and which further comprises a second label, where one of said first or second labels is a donor label and the other is an acceptor label, the donor label being able to donate fluorescent energy to the acceptor label; so as to form an amplification product incorporating a probe region, (b) subjecting amplification product to conditions under which the probe region thereof will hybridise to the complementary region of the amplification product, and (c)monitoring fluorescence of said sample and determining a particular reaction condition, characteristic of said sequence, at which fluorescence changes as a result of the hybridisation of the probe region to the sample or destabilisation of the duplex formed between the probe region and the target nucleic acid sequence. 15. A method for detecting a polymorphism and/or allelic variation, said method comprising amplifying a sequence suspected of containing said polymorphism or variation using a method as defined in claim 1, measuring the temperature at which the probe region melts from its complementary sequence within the amplification product using the fluorescent signal generated, and relating this to the presence of a polymorphism or allelic variation. 16. A method according to claim 2 wherein the acceptor label is a fluorescent molecule which emits energy at a characteristic wavelength. 17. A method according to claim 2 wherein the acceptor label is a dark acceptor such as DABCYL, Methyl Red or a QSY-7 diarylrhodamine dye.

Details for Patent 7,015,018

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2019-08-04
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2019-08-04
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2019-08-04